AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like SAb Biotherapeutics Integrates Operations With New Production Facility August 29, 2017 <b>VisualDx</b>???A Transformational Artificial Intelligence App For Iphone To Help Improve Diagnosis Of Diseases September 28, 2017 Puma Biotech Surges After the FDA Officially Approves Breast Cancer Drug July 17, 2017
<b>VisualDx</b>???A Transformational Artificial Intelligence App For Iphone To Help Improve Diagnosis Of Diseases September 28, 2017